H-1B sponsorship profile: Garuda Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Garuda Therapeutics, Inc filed 18 Labor Condition Applications covering 18 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (18 certified of 18 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Garuda Therapeutics, Inc’s H-1B petitions range from $76,613 at the low end to $385,700 at the high end, with a petition-weighted average of $180,021. That range reflects the mix of occupations the company sponsors, led by Computational Biologist - Senior Scientist I (5 petitions at $137,323 avg), followed by Process Development Research Associate and Medical Director. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Garuda Therapeutics, Inc is headquartered in Cambridge, MA under NAICS code 541714, and places H-1B workers across 2 states, most heavily in MA, CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Garuda Therapeutics, Inc ranks. By H-1B petition volume, Garuda Therapeutics, Inc is #10,965 of 119,880 employers nationally and #453 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.